A Novel Tight Junction–Nuclear Receptor Signaling Pathway Regulating Cancer Progression
Open Access
- 25 July 2025
- journal article
- review article
- Published by Wiley in Pathology International
- Vol. 75 (9) , 443-450
Abstract
Nuclear receptors (NRs) are lipid ligand‐binding transcription factors, with 48 members having been identified in humans to date. They are involved in diverse physiological processes, including development and homeostasis, and are also implicated in the pathogenesis of various diseases, most notably cancer. While NR activity is primarily regulated by specific ligand binding, posttranslational modifications, particularly phosphorylation, also play a critical role in modulating their function. Recently, we identified a novel signaling pathway linking claudins (CLDNs), cell‐cell adhesion proteins, to NRs. CLDN‐mediated cell‐cell adhesion activates Src family kinases (SFKs), leading to serine phosphorylation of several NRs. This newly‐discovered CLDN–NR pathway contributes to epithelial differentiation in stem cells and promotes cancer progression. In this review, we discuss the biological significance and underlying mechanisms of this, tracing the development of our research.Keywords
This publication has 79 references indexed in Scilit:
- Aberrant phosphorylation of human LRH1 at serine 510 is predictable of hepatocellular carcinoma recurrenceClinical and Experimental Medicine, 2023
- Vitamin D metabolism in cancer: potential feasibility of vitamin D metabolism blocking therapyMedical Molecular Morphology, 2023
- Retinoic acid metabolism in cancer: potential feasibility of retinoic acid metabolism blocking therapyMedical Molecular Morphology, 2023
- Estrogen Signaling in Endometrial Cancer: a Key Oncogenic Pathway with Several Open QuestionsDiscover Oncology, 2019
- Farnesoid X receptor, the bile acid sensing nuclear receptor, in liver regenerationActa Pharmaceutica Sinica B, 2015
- Genetic targeting of the endoderm with claudin‐6CreERDevelopmental Dynamics, 2008
- Claudin‐6: A novel tight junction molecule is developmentally regulated in mouse embryonic epitheliumDevelopmental Dynamics, 2001
- Retinoid X Receptor α and Retinoic Acid Receptor γ Mediate Expression of Genes Encoding Tight-Junction Proteins and Barrier Function in F9 Cells during Visceral Endodermal DifferentiationExperimental Cell Research, 2001
- F9 Embryonal Carcinoma Cells Engineered for Tamoxifen-Dependent Cre-Mediated Site-Directed Mutagenesis and Doxycycline-Inducible Gene ExpressionExperimental Cell Research, 2000
- The induction of differentiation in teratocarcinoma stem cells by retinoic acidCell, 1978